Glaukos Files For IPO

Laguna Hills-based Glaukos, which is developing a medical device to treat glaucoma, has filed for an IPO. According to Glaukos, it is looking to raised up to $86.25M in an IPO oon the New York Stock Exchange, under the symbol GKOS. The IPO is being underwritten by J.P. Morgan, BofA Merrill Lynch, Goldman Sachs & Co., William Blair, and Cantor Fitzgerald & Co. Glaukos is venture backed by Domain Associates, Verant Ventures, Frazier Healthcare, InterWest Partners, Montreux Equity, OrbiMed, Meritech Capital Partners, and others.